RUA Life Sciences (AOHA) Income Statement
RUA Life Sciences Income Statement
Last quarter (Q4 2025), RUA Life Sciences's total revenue was $2.59M, an increase of 85.33% from the same quarter last year. In Q4, RUA Life Sciences's net income was $-630.00K. See RUA Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| $ 4.11M | $ 2.19M | $ 2.18M | $ 1.63M | $ 1.53M | |
| $ 3.17M | $ 1.72M | $ 1.43M | $ 1.04M | $ 980.00K | |
| $ 3.19M | $ 3.40M | $ 3.82M | $ 3.47M | $ 2.80M | |
| Depreciation and Amortization | $ 421.00K | $ 364.00K | $ 358.00K | $ 313.00K | $ 272.00K |
| $ 401.00K | $ -1.57M | $ -1.95M | $ -2.04M | $ -1.28M | |
| $ -989.00K | $ -1.94M | $ -2.31M | $ -2.35M | $ -1.80M | |
| $ 979.00K | $ -83.00K | $ -16.00K | $ -8.00K | $ -43.00K | |
| $ -10.00K | $ -2.02M | $ -2.32M | $ -2.36M | $ -1.59M | |
| $ 1.00K | $ -1.44M | $ -2.00M | $ -2.07M | $ -1.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.00 | $ -0.04 | $ -0.09 | $ -0.09 | $ -0.08 |
| Diluted EPS | $ 0.00 | $ -0.04 | $ -0.09 | $ -0.09 | $ -0.08 |
| Weighted Average Shares Outstanding | 62.06M | 33.57M | 22.18M | 22.18M | 17.70M |
| Weighted Average Shares Outstanding (Diluted) | 62.06M | 33.57M | 22.18M | 22.18M | 17.70M |
Currency in GBP